Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients

Author(s):
Maagdenberg, H.; Bierings, M.B.; Ommen, C.H. van; Meer, F.J.M. van der (0000-0002-0221-9618); Appel, I.M.; Tamminga, R.Y.J.; Cessie, S. le (0000-0003-2154-4923); Swen, J.J.; Straaten, T. van der; Boer, A. de; Maitland-van der Zee, A.H.
Published
2018
Publication type
Article / Letter to editor
adolescentanticoagulationchildinfantpharmacogenomicsphenprocoumonthrombosis
Date issued
2018-10-31
Language
English
Is part of
Pharmacogenomics (2018), Vol. 19, no. 15, p. 1195-1202
hdl
1887/95619
doi
10.2217/pgs-2018-0095